Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1327-1336

  Powell, Pnina K ^a   Wolf, Imre ^a   Jin, Rongyu ^a   Lasker, Jerome M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

19 HYDROXY 5,8,11,14 ICOSATETRAENOIC ACID; 20 HYDROXY 5,8,11,14 ICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; HYDROXYICOSATETRAENOIC ACID; LIVER ENZYME; MICROSOME ENZYME; OXYGENASE; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; HUMAN; HUMAN TISSUE; HYDROXYLATION; KIDNEY; LIVER METABOLISM; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKANE 1-MONOOXYGENASE; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES;

EID: 0031808169     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Alterman M, Chaurasia C, Lu P, Hardwick J and Hanzlik R (1995) Fatty acid discrimination and ω-hydroxylation by cytochrome P4504A1 and a cytochrome P4504A1/NADPH:P450 reductase fusion protein. Arch Biochem Biophys 320:289-296.
2. Amet Y, Berthou F, Fournier G, Dreano Y, Bardou L, Cledes J and Menez J-F (1997) Cytochrome P4504A and 2E1 expression in human kidney microsomes. Biochem Pharmacol 53:765-771.
3. Brash A, Boeglin W, Capdevila J, Yeola S and Blair I (1995) 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent arachidonic acid metabolism in rat liver microsomes: analysis of their stereochemistry, and the stereochemistry of their acid-catalyzed rearrangement. Arch Biochem Biophys 321:485-492.
4. Capdevila J, Falck J, Dishman E and Karara A (1990a) Cytochrome P450 arachidonate oxygenase. Methods Enzymol 187:385-394.
5. Capdevila JH, Falck JR and Estabrook RW (1992) Cytochrome P450 and the arachidonate cascade. FASEB J 6:731-736.
6. Capdevila JH, Karara A, Waxman DJ, Martin MV, Falck JR and Guengerich FP (1990b) Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem 265: 10865-10871.
7. Capdevila JH, Zeldin D, Makita K, Karara A and Falck JR (1995) Cytochrome P450 and the metabolism of arachidonic acid and oxygenated eicosanoids, in Cytochrome P 450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., Ed.) 2nd ed, pp 443-471, Plenum Press, New York.
8. Chen L and Hardwick JP (1994) The human CYP4F2 gene cDNA sequence and catalytic activity of baculovirus-infected insect cells. FASEB J 8:A1257.
9. Daikh BE, Lasker JM, Raucy JL and Koop DR (1994) Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 271:1427-33.
10. Escalante B, Sessa W, Falck J, Yadagiri P and Laniado-Schwartzman M (1989) Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent upon metabolism by cyclooxygenase. J Pharmacol Exp Ther 248:229-232.
11. Falck JR, Lumin S, Blair I, Dishman E, Martin MV, Waxman DJ, Guengerich FP and Capdevila JH (1990) Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J Biol Chem 265:10244-10249.
12. Ferguson N, Donahue B, Tenney K and Morgan E (1993) Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment. Drug Metab Dispos 21:745-756.
13. Gibson G (1996) Peroxisome proliferates and cytochrome P4504A induction. Ann NY Acad Sci 804:328-365.
14. Gibson GG (1989) Comparative aspects of the mammalian cytochrome P450 IV gene family. Xenobiotica 19:1123-1148.
15. Harder D, Campbell W and Roman R (1995) Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32:79-92.
16. Harder DR, Lange AR, Gebremedhin D, Birks EK and Roman RJ (1997) Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 34:237-243.
17. Hatzelmann A and Ullrich V (1988) The omega-hydroxylation of arachidonic acid by human polymorphonuclear leukocytes. Eur J Biochem 173:445-452.
18. Imaoka S and Funae Y (1991) Hepatic and renal cytochrome P-450s in spontaneously hypertensive rats. Biochim Biophys Acta 1074:209-213.
19. Imaoka S, Ogawa H, Kimura S and Gonzalez FJ (1993) Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid w-hydroxylase expressed in human kidney. DNA Cell Biol 12:893-899.
20. Kawashima H, Kusunose E, Kikuta Y, Kinoshita H, Tanaka S, Yamamoto S, Kishimoto T and Kusonose M (1994) Purification and cDNA cloning of human liver CYP4A fatty acid ω-hydroxylase. J Biochem (Tokyo) 116:74-80.
21. Kawashima H, Kusunose E, Kubota I, Maekawa M and Kusunose M (1992) Purification and NH2-terminal amino acid sequences of human and rat kidney fatty acid ω-hydroxylases. Biochim Biophys Acta 1123:156-162.
22. Kikuta Y, Kusunose E, Kondo T, Yamamoto S, Kinoshita H and Kusonose M (1994) Cloning and expression of a novel form of leukotriene B4 w-hydroxylase from human liver. FEBS Lett 348:70-74.
23. Laethem RM, Balazy M, Falck JR, Laethem CL and Koop DR (1993) Formation of 19(S)-, 19(R), and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P4502E1. J Biol Chem 268:12912-12918.
24. Laethem RM and Koop DR (1992) Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases. Mol Pharmacol 42:958-963.
25. Laethem RM, Laethem CL and DRK (1992) Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. J Biol Chem 267:5552-5559.
26. Lasker JM, Raucy JL, Daikh BE, Aramsombatdee E and Koop DR (1994) Purification and properties of human liver CYP4A12 and CYP4F4, in Proceedings of the 10th International Symposium on Microsomes and Drug Oxidations (abstract). 10:282.
27. Lasker JM, Wester MR, Aramsombatdee E and Raucy JL (1998) Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Arch Biochem Biophys in press.
28. Ma X, Baraona E and Lieber CS (1993) Alcohol consumption enhances fatty acid w-oxidation, with a greater increase in male than in female rats. Hepatology 18:1247-1253.
29. Matsubara S, Yamamoto S, Sogawa K, Yokotani N, Fujii-Kuriyama Y, Haniu, M, Shively J, Gotoh O, Kusunose E and Kusunose M (1987) cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2). J Biol Chem 262:13366-13371.
30. McGiff JC (1991) Cytochrome P450-dependent metabolism of arachidonic acid. Ann Rev Pharmacol Toxicol 31:339-369.
31. Nanji AA, Zhao S, Lamb RG, Dannenberg AJ, Sadrzadeh SMH and Waxman DJ (1994) Changes in cytochromes P450 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. Alcoholism: Clin Exp Res 18:902-908.
32. Needleman P, Turk J, Jakschik BA, Morrison AR and Lefkowith JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:62-102.
33. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus, IC and Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession number, and nomenclature. Pharmacogenetics 6:1-42.
34. Okita JR, Castle PJ and Okita RT (1993) Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J Biochem Toxicol 8:135-144.
35. Okita R, Clark J, Okita J and Masters B (1991) Determination of ω- and ω-1 hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatography. Methods Enzymol 206:432-441.
36. Okita RT and Okita JR (1992) Characterization of a cytochrome P450 from di(2-ethylhexyl)phthalate-treated rats which hydroxylates fatty acids. Arch Biochem Biophys 294:1475-1481.
37. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
38. Palmer CNA, Richardson TH, Griffin KJ, Hsu M-H, Muerhoff AS, Clark JE and Johnson EF (1993) Characterization of a cDNA encoding a human kidney cytochrome P4504A fatty acid ω-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim Biophys Acta 1172:161-166.
39. Powell PK, Wolf I and Lasker JM (1996) Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Arch Biochem Biophys 335:219-226.
40. Rahman M, Wright JJ and Douglas J (1997) The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function. Am J Hypertens 10:356-365.
41. Raucy JL and Lasker JM (1991) Isolation of P450 enzymes from human liver. Methods Enzymol 206:577-87.
42. Rifkind AB, Lee C, Chang TKH and Waxman DJ (1995) Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid metabolism by human liver microsomes. Arch Biochem Biophys 320:380-389.
43. Roman LJ, Palmer CNA, Clark JE, Muerhoff AS, Griffin KJ, Johnson EF and Masters BSS (1993) Expression of rabbit cytochromes P4504A which catalyze the w-hydroxylation of arachidonic acid, fatty acids, and prostaglandins. Arch Biochem Biophys 307:57-65.
44. Schwartzman ML, da Silva JL, Lin F, Nishimura M and Abraham NG (1996) Cytochrome P4504A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 73:652-663.
45. Schwartzman ML, Martasek P, Rios AR, Levere RD, Solangi K, Goodman AI and Abraham NG (1990) Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 37:94-99.
46. Shimojo N, Ishizaki T, Imaoka S, Funae Y, Fujii S and Okuda K (1993) Changes in the amount of cytochrome P450 isozymes and levels of catalytic activities in hepatic and adrenal microsomes of rats with streptozocin-induced diabetes. Biochem Pharmacol 46:621-627.
47. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
48. Smith WL (1992) Prostanoid biosynthesis and mechanism of action. Am J Physiol 263:383-417.
49. Smith WL, Marnett LJ and DeWitt DL (1991) Prostaglandin and thromboxane biosynthesis. Pharmacol Rev 49:153-179.
50. Stec DE, Mattson DL and Roman RJ (1997) Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension 29:315-319.
51. Tsutsumi M, Lasker JM, Takahashi T and Lieber CS (1993) In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 304:209-18.
52. Wang M-H, Stec D, Balazy M, Mastyugin V, Yang C, Roman R and Schwartzman M (1996) Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch Biochem Biophys 336:240-250.
53. Yoshimura R, Kusunose E, Yokotani N, Yamamoto S, Kubota I and Kusunose M (1990) Purification and characterization of two forms of fatty acid w-hydroxylase cytochrome P-450 from rabbit kidney cortex microsomes. J Biochem (Tokyo) 108: 544-548.
54. Zeldin D, Moomaw C, Jesse N, Tomer K, Beetham J, Hammock B and Wu S (1996) Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330:87-96.